BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 15035882)

  • 1. A population-based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer.
    Eng J; Ramsum D; Verhoef M; Guns E; Davison J; Gallagher R
    Integr Cancer Ther; 2003 Sep; 2(3):212-6. PubMed ID: 15035882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the motivation for conventional and complementary/alternative medicine use among men with prostate cancer.
    Singh H; Maskarinec G; Shumay DM
    Integr Cancer Ther; 2005 Jun; 4(2):187-94. PubMed ID: 15911931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total and specific complementary and alternative medicine use in a large cohort of men with prostate cancer.
    Chan JM; Elkin EP; Silva SJ; Broering JM; Latini DM; Carroll PR
    Urology; 2005 Dec; 66(6):1223-8. PubMed ID: 16360447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, demographic and psychosocial correlates of complementary and alternative medicine use by men diagnosed with localized prostate cancer.
    Diefenbach MA; Hamrick N; Uzzo R; Pollack A; Horwitz E; Greenberg R; Engstrom PF
    J Urol; 2003 Jul; 170(1):166-9. PubMed ID: 12796672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the role of evidence in patients' evaluation of complementary therapies: a quality study.
    Verhoef MJ; Mulkins A; Carlson LE; Hilsden RJ; Kania A
    Integr Cancer Ther; 2007 Dec; 6(4):345-53. PubMed ID: 18048882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of complementary/alternative medicine by cancer patients in a New Zealand regional cancer treatment centre.
    Chrystal K; Allan S; Forgeson G; Isaacs R
    N Z Med J; 2003 Jan; 116(1168):U296. PubMed ID: 12601420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of complementary and alternative medicine in men with family history of prostate cancer: a pilot study.
    Beebe-Dimmer JL; Wood DP; Gruber SB; Douglas JA; Bonner JD; Mohai C; Zuhlke KA; Shepherd C; Cooney KA
    Urology; 2004 Feb; 63(2):282-7. PubMed ID: 14972472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study of the use of alternative therapies by men with localized prostate cancer.
    Steginga SK; Occhipinti S; Gardiner RA; Yaxley J; Heathcote P
    Patient Educ Couns; 2004 Oct; 55(1):70-7. PubMed ID: 15476992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Men with prostate cancer: making decisions about complementary/alternative medicine.
    Boon H; Brown JB; Gavin A; Westlake K
    Med Decis Making; 2003; 23(6):471-9. PubMed ID: 14672107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why some cancer patients choose complementary and alternative medicine instead of conventional treatment.
    Shumay DM; Maskarinec G; Kakai H; Gotay CC;
    J Fam Pract; 2001 Dec; 50(12):1067. PubMed ID: 11742609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Problem-solving and decision-making preferences: no difference between complementary and alternative medicine users and non-users.
    Boon H; Westlake K; Deber R; Moineddin R
    Complement Ther Med; 2005 Sep; 13(3):213-6. PubMed ID: 16150376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing patterns of CAM use among prostate cancer patients two years after diagnosis: reasons for maintenance or discontinuation.
    Porter M; Kolva E; Ahl R; Diefenbach MA
    Complement Ther Med; 2008 Dec; 16(6):318-24. PubMed ID: 19028331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementary and alternative medicine use by women after completion of allopathic treatment for breast cancer.
    Henderson JW; Donatelle RJ
    Altern Ther Health Med; 2004; 10(1):52-7. PubMed ID: 14727500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of complementary medicine by adult patients participating in cancer clinical trials.
    Sparber A; Bauer L; Curt G; Eisenberg D; Levin T; Parks S; Steinberg SM; Wootton J
    Oncol Nurs Forum; 2000 May; 27(4):623-30. PubMed ID: 10833691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and testing of the use of a complementary and alternative therapies survey in women with breast cancer.
    Lengacher CA; Bennett MP; Kipp KE; Berarducci A; Cox CE
    Oncol Nurs Forum; 2003; 30(5):811-21. PubMed ID: 12949594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nationwide survey on complementary and alternative medicine in cancer patients in Japan.
    Hyodo I; Amano N; Eguchi K; Narabayashi M; Imanishi J; Hirai M; Nakano T; Takashima S
    J Clin Oncol; 2005 Apr; 23(12):2645-54. PubMed ID: 15728227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementary and alternative medicine use in lung cancer patients in eight European countries.
    Molassiotis A; Panteli V; Patiraki E; Ozden G; Platin N; Madsen E; Browall M; Fernandez-Ortega P; Pud D; Margulies A
    Complement Ther Clin Pract; 2006 Feb; 12(1):34-9. PubMed ID: 16401528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of complementary and alternative medicine among cancer patients in Israel.
    Pud D; Kaner E; Morag A; Ben-Ami S; Yaffe A
    Eur J Oncol Nurs; 2005 Jun; 9(2):124-30. PubMed ID: 15944105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of use of complementary and alternative medicine in women with breast cancer.
    Lengacher CA; Bennett MP; Kip KE; Keller R; LaVance MS; Smith LS; Cox CE
    Oncol Nurs Forum; 2002; 29(10):1445-52. PubMed ID: 12432415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementary and alternative medicine use among colorectal cancer patients in Alberta, Canada.
    Tough SC; Johnston DW; Verhoef MJ; Arthur K; Bryant H
    Altern Ther Health Med; 2002; 8(2):54-6, 58-60, 62-4. PubMed ID: 11890386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.